PubMed:20332301
Annnotations
Inflammaging
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T1 | 0-169 | Sentence | denotes | Vaccine against MUC1 antigen expressed in inflammatory bowel disease and cancer lessens colonic inflammation and prevents progression to colitis-associated colon cancer. |
| T2 | 170-342 | Sentence | denotes | Association of chronic inflammation with an increased risk of cancer is well established, but the contributions of innate versus adaptive immunity are not fully delineated. |
| T3 | 343-553 | Sentence | denotes | There has furthermore been little consideration of the role played by chronic inflammation-associated antigens, including cancer antigens, and the possibility of using them as vaccines to lower the cancer risk. |
| T4 | 554-744 | Sentence | denotes | We studied the human tumor antigen MUC1 which is abnormally expressed in colon cancers and also in inflammatory bowel disease (IBD) that gives rise to colitis-associated colon cancer (CACC). |
| T5 | 745-957 | Sentence | denotes | Using our new mouse model of MUC1(+) IBD that progresses to CACC, interleukin-10 knockout mice crossed with MUC1 transgenic mice, we show that vaccination against MUC1 delays IBD and prevents progression to CACC. |
| T6 | 958-1121 | Sentence | denotes | One mechanism is the induction of MUC1-specific adaptive immunity (anti-MUC1 IgG and anti-MUC1 CTL), which seems to eliminate abnormal MUC1(+) cells in IBD colons. |
| T7 | 1122-1204 | Sentence | denotes | The other mechanism is the change in the local and the systemic microenvironments. |
| T8 | 1205-1441 | Sentence | denotes | Compared with IBD in vaccinated mice, IBD in control mice is dominated by larger numbers of neutrophils in the colon and myeloid-derived suppressor cells in the spleen, which can compromise adaptive immunity and facilitate tumor growth. |
| T9 | 1442-1642 | Sentence | denotes | This suggests that the tumor-promoting microenvironment of chronic inflammation can be converted to a tumor-inhibiting environment by increasing adaptive immunity against a disease-associated antigen. |
| T1 | 0-169 | Sentence | denotes | Vaccine against MUC1 antigen expressed in inflammatory bowel disease and cancer lessens colonic inflammation and prevents progression to colitis-associated colon cancer. |
| T2 | 170-342 | Sentence | denotes | Association of chronic inflammation with an increased risk of cancer is well established, but the contributions of innate versus adaptive immunity are not fully delineated. |
| T3 | 343-553 | Sentence | denotes | There has furthermore been little consideration of the role played by chronic inflammation-associated antigens, including cancer antigens, and the possibility of using them as vaccines to lower the cancer risk. |
| T4 | 554-744 | Sentence | denotes | We studied the human tumor antigen MUC1 which is abnormally expressed in colon cancers and also in inflammatory bowel disease (IBD) that gives rise to colitis-associated colon cancer (CACC). |
| T5 | 745-957 | Sentence | denotes | Using our new mouse model of MUC1(+) IBD that progresses to CACC, interleukin-10 knockout mice crossed with MUC1 transgenic mice, we show that vaccination against MUC1 delays IBD and prevents progression to CACC. |
| T6 | 958-1121 | Sentence | denotes | One mechanism is the induction of MUC1-specific adaptive immunity (anti-MUC1 IgG and anti-MUC1 CTL), which seems to eliminate abnormal MUC1(+) cells in IBD colons. |
| T7 | 1122-1204 | Sentence | denotes | The other mechanism is the change in the local and the systemic microenvironments. |
| T8 | 1205-1441 | Sentence | denotes | Compared with IBD in vaccinated mice, IBD in control mice is dominated by larger numbers of neutrophils in the colon and myeloid-derived suppressor cells in the spleen, which can compromise adaptive immunity and facilitate tumor growth. |
| T9 | 1442-1642 | Sentence | denotes | This suggests that the tumor-promoting microenvironment of chronic inflammation can be converted to a tumor-inhibiting environment by increasing adaptive immunity against a disease-associated antigen. |
sentences
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| TextSentencer_T1 | 0-169 | Sentence | denotes | Vaccine against MUC1 antigen expressed in inflammatory bowel disease and cancer lessens colonic inflammation and prevents progression to colitis-associated colon cancer. |
| TextSentencer_T2 | 170-342 | Sentence | denotes | Association of chronic inflammation with an increased risk of cancer is well established, but the contributions of innate versus adaptive immunity are not fully delineated. |
| TextSentencer_T3 | 343-553 | Sentence | denotes | There has furthermore been little consideration of the role played by chronic inflammation-associated antigens, including cancer antigens, and the possibility of using them as vaccines to lower the cancer risk. |
| TextSentencer_T4 | 554-744 | Sentence | denotes | We studied the human tumor antigen MUC1 which is abnormally expressed in colon cancers and also in inflammatory bowel disease (IBD) that gives rise to colitis-associated colon cancer (CACC). |
| TextSentencer_T5 | 745-957 | Sentence | denotes | Using our new mouse model of MUC1(+) IBD that progresses to CACC, interleukin-10 knockout mice crossed with MUC1 transgenic mice, we show that vaccination against MUC1 delays IBD and prevents progression to CACC. |
| TextSentencer_T6 | 958-1121 | Sentence | denotes | One mechanism is the induction of MUC1-specific adaptive immunity (anti-MUC1 IgG and anti-MUC1 CTL), which seems to eliminate abnormal MUC1(+) cells in IBD colons. |
| TextSentencer_T7 | 1122-1204 | Sentence | denotes | The other mechanism is the change in the local and the systemic microenvironments. |
| TextSentencer_T8 | 1205-1441 | Sentence | denotes | Compared with IBD in vaccinated mice, IBD in control mice is dominated by larger numbers of neutrophils in the colon and myeloid-derived suppressor cells in the spleen, which can compromise adaptive immunity and facilitate tumor growth. |
| TextSentencer_T9 | 1442-1642 | Sentence | denotes | This suggests that the tumor-promoting microenvironment of chronic inflammation can be converted to a tumor-inhibiting environment by increasing adaptive immunity against a disease-associated antigen. |
| T1 | 0-169 | Sentence | denotes | Vaccine against MUC1 antigen expressed in inflammatory bowel disease and cancer lessens colonic inflammation and prevents progression to colitis-associated colon cancer. |
| T2 | 170-342 | Sentence | denotes | Association of chronic inflammation with an increased risk of cancer is well established, but the contributions of innate versus adaptive immunity are not fully delineated. |
| T3 | 343-553 | Sentence | denotes | There has furthermore been little consideration of the role played by chronic inflammation-associated antigens, including cancer antigens, and the possibility of using them as vaccines to lower the cancer risk. |
| T4 | 554-744 | Sentence | denotes | We studied the human tumor antigen MUC1 which is abnormally expressed in colon cancers and also in inflammatory bowel disease (IBD) that gives rise to colitis-associated colon cancer (CACC). |
| T5 | 745-957 | Sentence | denotes | Using our new mouse model of MUC1(+) IBD that progresses to CACC, interleukin-10 knockout mice crossed with MUC1 transgenic mice, we show that vaccination against MUC1 delays IBD and prevents progression to CACC. |
| T6 | 958-1121 | Sentence | denotes | One mechanism is the induction of MUC1-specific adaptive immunity (anti-MUC1 IgG and anti-MUC1 CTL), which seems to eliminate abnormal MUC1(+) cells in IBD colons. |
| T7 | 1122-1204 | Sentence | denotes | The other mechanism is the change in the local and the systemic microenvironments. |
| T8 | 1205-1441 | Sentence | denotes | Compared with IBD in vaccinated mice, IBD in control mice is dominated by larger numbers of neutrophils in the colon and myeloid-derived suppressor cells in the spleen, which can compromise adaptive immunity and facilitate tumor growth. |
| T9 | 1442-1642 | Sentence | denotes | This suggests that the tumor-promoting microenvironment of chronic inflammation can be converted to a tumor-inhibiting environment by increasing adaptive immunity against a disease-associated antigen. |
DisGeNET
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T0 | 1048-1052 | gene:4582 | denotes | MUC1 |
| T1 | 1110-1113 | disease:C0021390 | denotes | IBD |
| T2 | 1093-1097 | gene:4582 | denotes | MUC1 |
| T3 | 1110-1113 | disease:C0021390 | denotes | IBD |
| R1 | T0 | T1 | associated_with | MUC1,IBD |
| R2 | T2 | T3 | associated_with | MUC1,IBD |
PubmedHPO
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T1 | 232-238 | HP_0002664 | denotes | cancer |
| T2 | 465-471 | HP_0002664 | denotes | cancer |
| T3 | 541-547 | HP_0002664 | denotes | cancer |
| T4 | 575-580 | HP_0002664 | denotes | tumor |
| T5 | 627-640 | HP_0003003 | denotes | colon cancers |
| T6 | 627-640 | HP_0100273 | denotes | colon cancers |
| T7 | 633-640 | HP_0002664 | denotes | cancers |
| T8 | 724-736 | HP_0003003 | denotes | colon cancer |
| T9 | 724-736 | HP_0100273 | denotes | colon cancer |
| T10 | 730-736 | HP_0002664 | denotes | cancer |
| T11 | 1428-1433 | HP_0002664 | denotes | tumor |
| T12 | 1465-1470 | HP_0002664 | denotes | tumor |
| T13 | 1544-1549 | HP_0002664 | denotes | tumor |
Allie
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| SS1_20332301_3_0 | 653-679 | expanded | denotes | inflammatory bowel disease |
| SS2_20332301_3_0 | 681-684 | abbr | denotes | IBD |
| SS1_20332301_3_1 | 705-736 | expanded | denotes | colitis-associated colon cancer |
| SS2_20332301_3_1 | 738-742 | abbr | denotes | CACC |
| AE1_20332301_3_0 | SS1_20332301_3_0 | SS2_20332301_3_0 | abbreviatedTo | inflammatory bowel disease,IBD |
| AE1_20332301_3_1 | SS1_20332301_3_1 | SS2_20332301_3_1 | abbreviatedTo | colitis-associated colon cancer,CACC |
DisGeNET5_gene_disease
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| 20332301-0#16#20#gene4582 | 16-20 | gene4582 | denotes | MUC1 |
| 20332301-0#156#168#diseaseC0007102 | 156-168 | diseaseC0007102 | denotes | colon cancer |
| 20332301-0#156#168#diseaseC0699790 | 156-168 | diseaseC0699790 | denotes | colon cancer |
| 20332301-0#42#68#diseaseC0021390 | 42-68 | diseaseC0021390 | denotes | inflammatory bowel disease |
| 20332301-0#137#144#diseaseC0009319 | 137-144 | diseaseC0009319 | denotes | colitis |
| 20332301-3#21#34#gene404663 | 575-588 | gene404663 | denotes | tumor antigen |
| 20332301-3#73#86#diseaseC0007102 | 627-640 | diseaseC0007102 | denotes | colon cancers |
| 20332301-3#99#125#diseaseC0021390 | 653-679 | diseaseC0021390 | denotes | inflammatory bowel disease |
| 20332301-3#127#130#diseaseC0021390 | 681-684 | diseaseC0021390 | denotes | IBD |
| 20332301-3#151#158#diseaseC0009319 | 705-712 | diseaseC0009319 | denotes | colitis |
| 20332301-4#66#80#gene3586 | 811-825 | gene3586 | denotes | interleukin-10 |
| 20332301-4#175#178#diseaseC0021390 | 920-923 | diseaseC0021390 | denotes | IBD |
| 16#20#gene4582156#168#diseaseC0007102 | 20332301-0#16#20#gene4582 | 20332301-0#156#168#diseaseC0007102 | associated_with | MUC1,colon cancer |
| 16#20#gene4582156#168#diseaseC0699790 | 20332301-0#16#20#gene4582 | 20332301-0#156#168#diseaseC0699790 | associated_with | MUC1,colon cancer |
| 16#20#gene458242#68#diseaseC0021390 | 20332301-0#16#20#gene4582 | 20332301-0#42#68#diseaseC0021390 | associated_with | MUC1,inflammatory bowel disease |
| 16#20#gene4582137#144#diseaseC0009319 | 20332301-0#16#20#gene4582 | 20332301-0#137#144#diseaseC0009319 | associated_with | MUC1,colitis |
| 21#34#gene40466373#86#diseaseC0007102 | 20332301-3#21#34#gene404663 | 20332301-3#73#86#diseaseC0007102 | associated_with | tumor antigen,colon cancers |
| 21#34#gene40466399#125#diseaseC0021390 | 20332301-3#21#34#gene404663 | 20332301-3#99#125#diseaseC0021390 | associated_with | tumor antigen,inflammatory bowel disease |
| 21#34#gene404663127#130#diseaseC0021390 | 20332301-3#21#34#gene404663 | 20332301-3#127#130#diseaseC0021390 | associated_with | tumor antigen,IBD |
| 21#34#gene404663151#158#diseaseC0009319 | 20332301-3#21#34#gene404663 | 20332301-3#151#158#diseaseC0009319 | associated_with | tumor antigen,colitis |
| 66#80#gene3586175#178#diseaseC0021390 | 20332301-4#66#80#gene3586 | 20332301-4#175#178#diseaseC0021390 | associated_with | interleukin-10,IBD |
DisGeNet-2017-sample
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T2463 | 16-20 | gene:4582 | denotes | MUC1 |
| T2464 | 156-168 | disease:C0007102 | denotes | colon cancer |
| R1 | T2463 | T2464 | associated_with | MUC1,colon cancer |
| R2 | T2463 | T2464 | associated_with | MUC1,colon cancer |
UBERON-AE
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| PD-UBERON-AE-B_T1 | 88-95 | http://purl.obolibrary.org/obo/UBERON_0001155 | denotes | colonic |
| PD-UBERON-AE-B_T2 | 156-161 | http://purl.obolibrary.org/obo/UBERON_0001155 | denotes | colon |
| PD-UBERON-AE-B_T3 | 627-632 | http://purl.obolibrary.org/obo/UBERON_0001155 | denotes | colon |
| PD-UBERON-AE-B_T4 | 724-729 | http://purl.obolibrary.org/obo/UBERON_0001155 | denotes | colon |
| PD-UBERON-AE-B_T5 | 1316-1321 | http://purl.obolibrary.org/obo/UBERON_0001155 | denotes | colon |
| PD-UBERON-AE-B_T6 | 1366-1372 | http://purl.obolibrary.org/obo/UBERON_0002106 | denotes | spleen |
performance-test
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| PD-UBERON-AE-B_T1 | 88-95 | http://purl.obolibrary.org/obo/UBERON_0001155 | denotes | colonic |
| PD-UBERON-AE-B_T2 | 156-161 | http://purl.obolibrary.org/obo/UBERON_0001155 | denotes | colon |
| PD-UBERON-AE-B_T3 | 627-632 | http://purl.obolibrary.org/obo/UBERON_0001155 | denotes | colon |
| PD-UBERON-AE-B_T4 | 724-729 | http://purl.obolibrary.org/obo/UBERON_0001155 | denotes | colon |
| PD-UBERON-AE-B_T5 | 1114-1120 | http://purl.obolibrary.org/obo/UBERON_0001155 | denotes | colons |
| PD-UBERON-AE-B_T6 | 1316-1321 | http://purl.obolibrary.org/obo/UBERON_0001155 | denotes | colon |
| PD-UBERON-AE-B_T7 | 1366-1372 | http://purl.obolibrary.org/obo/UBERON_0002106 | denotes | spleen |